Royal Fund Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
40,532
+1,022
+3% +$47.4K 0.16% 147
2026
Q1
$1.73M Sell
39,510
-903
-2% -$41.2K 0.16% 151
2025
Q4
$1.79M Buy
40,413
+10,415
+35% +$449K 0.16% 136
2025
Q3
$1.27M Sell
29,998
-7,214
-19% -$291K 0.15% 145
2025
Q2
$1.36M Buy
37,212
+3,805
+11% +$141K 0.14% 174
2025
Q1
$1.27M Buy
33,407
+1,326
+4% +$49.3K 0.14% 174
2024
Q4
$1.21M Sell
32,081
-28,653
-47% -$1.14M 0.11% 173
2024
Q3
$2.47M Buy
60,734
+28,329
+87% +$1.07M 0.15% 144
2024
Q2
$1.11M Sell
32,405
-5,050
-13% -$159K 0.09% 183
2024
Q1
$1.19M Buy
37,455
+1,799
+5% +$54.7K 0.12% 187
2023
Q4
$1.09M Buy
35,656
+369
+1% +$11.8K 0.12% 182
2023
Q3
$1.17M Buy
35,287
+537
+2% +$17.2K 0.16% 153
2023
Q2
$1.07M Sell
34,750
-3,433
-9% -$99.2K 0.13% 158
2023
Q1
$1.05M Buy
38,183
+4,668
+14% +$130K 0.15% 150
2022
Q4
$937K Buy
33,515
+4,625
+16% +$139K 0.15% 125
2022
Q3
$851K Buy
28,890
+4,655
+19% +$146K 0.15% 118
2022
Q2
$683K Buy
24,235
+9,804
+68% +$279K 0.11% 129
2022
Q1
$449K Buy
14,431
+2,410
+20% +$71.1K 0.07% 151
2021
Q4
$355K Buy
12,021
+1,333
+12% +$38.9K 0.05% 154
2021
Q3
$320K Buy
10,688
+838
+9% +$28.8K 0.05% 152
2021
Q2
$357K Buy
9,850
+599
+6% +$22.2K 0.06% 147
2021
Q1
$338K Buy
9,251
+165
+2% +$6.07K 0.06% 144
2020
Q4
$330K Sell
9,086
-641
-7% -$21.7K 0.07% 133
2020
Q3
$291K Sell
9,727
-278
-3% -$8.68K 0.07% 130
2020
Q2
$297K Buy
10,005
+1,814
+22% +$53.7K 0.1% 122
2020
Q1
$217K Buy
8,191
+447
+6% +$17K 0.09% 134
2019
Q4
$327K Buy
7,744
+1,172
+18% +$49.6K 0.08% 112
2019
Q3
$274K Sell
6,572
-290
-4% -$11.3K 0.08% 109
2019
Q2
$252K Sell
6,862
-504
-7% -$18.4K 0.07% 111
2019
Q1
$281K Buy
7,366
+517
+8% +$19.2K 0.09% 106
2018
Q4
$240K Buy
6,849
+63
+0.9% +$2.19K 0.1% 95
2018
Q3
$222K Sell
6,786
-3,018
-31% -$96.1K 0.07% 111
2018
Q2
$303K Buy
9,804
+707
+8% +$20.2K 0.1% 92
2018
Q1
$245K Buy
9,097
+4,167
+85% +$111K 0.09% 105
2017
Q4
$135K Buy
4,930
+417
+9% +$12K 0.05% 133
2017
Q3
$144K Buy
4,513
+474
+12% +$15.2K 0.06% 99
2017
Q2
$133K Buy
4,039
+1,785
+79% +$59.1K 0.06% 99
2017
Q1
$74K Buy
2,254
+117
+5% +$3.76K 0.04% 126
2016
Q4
$66K Buy
+2,137
New +$66K 0.04% 131

Other funds holding OHI

Royal Fund Management's OHI Position: Q2 2026 in Review

Royal Fund Management increased its Omega Healthcare (OHI) stake by 2.6% in Q2 2026, buying an estimated $47.4K and bringing the position to 40,532 shares worth $1.93M. The position accounts for 0.16% of the portfolio, ranked #147.

Royal Fund Management first reported a position in OHI in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.47M in Q3 2024. 195 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Royal Fund Management held 40,532 shares of Omega Healthcare worth $1.93M as of Q2 2026.
  • Royal Fund Management bought 1,022 Omega Healthcare shares in Q2 2026, an estimated $47.4K.
  • Omega Healthcare made up 0.16% of Royal Fund Management's portfolio in Q2 2026, its #147 holding.
  • Royal Fund Management first reported a position in Omega Healthcare in Q4 2016 and has held it in 39 quarters since.
  • Royal Fund Management's Omega Healthcare position peaked at $2.47M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.